bioAffinity Technologies, Inc. Other Nonoperating Income (Expense)
bioAffinity Technologies, Inc. (BIAF) reported Other Nonoperating Income (Expense) of $1 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2024-08-14
- bioAffinity Technologies, Inc. other nonoperating income (expense) for the quarter ending 2024-06-30 was $1.00.
- bioAffinity Technologies, Inc. other nonoperating income (expense) for the quarter ending 2024-03-31 was $4.51K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month |
|---|---|---|
| 2024-06-30 | $1.00 10-Q · filed 2024-08-14 | $4.51K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.51K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |